126 related articles for article (PubMed ID: 1497800)
1. p53 gene mutations in human endometrial carcinoma.
Risinger JI; Dent GA; Ignar-Trowbridge D; McLachlan JA; Tsao MS; Senterman M; Boyd J
Mol Carcinog; 1992; 5(4):250-3. PubMed ID: 1497800
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
3. Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis.
Naito M; Satake M; Sakai E; Hirano Y; Tsuchida N; Kanzaki H; Ito Y; Mori T
Jpn J Cancer Res; 1992 Oct; 83(10):1030-6. PubMed ID: 1333465
[TBL] [Abstract][Full Text] [Related]
4. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.
Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR
Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567
[TBL] [Abstract][Full Text] [Related]
6. Involvement of p53 gene mutations in human endometrial carcinomas.
Honda T; Kato H; Imamura T; Gima T; Nishida J; Sasaki M; Hoshi K; Sato A; Wake N
Int J Cancer; 1993 Apr; 53(6):963-7. PubMed ID: 8473053
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
8. Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients.
Kihana T; Hamada K; Inoue Y; Yano N; Iketani H; Murao S; Ukita M; Matsuura S
Cancer; 1995 Jul; 76(1):72-8. PubMed ID: 8630879
[TBL] [Abstract][Full Text] [Related]
9. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias.
Kohler MF; Nishii H; Humphrey PA; Saski H; Marks J; Bast RC; Clarke-Pearson DL; Boyd J; Berchuck A
Am J Obstet Gynecol; 1993 Sep; 169(3):690-4. PubMed ID: 8372881
[TBL] [Abstract][Full Text] [Related]
11. Frequent mutation of the p53 gene in human esophageal cancer.
Hollstein MC; Metcalf RA; Welsh JA; Montesano R; Harris CC
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9958-61. PubMed ID: 2263646
[TBL] [Abstract][Full Text] [Related]
12. p53 protein accumulation and gene mutations in human glioma cell lines.
Anker L; Ohgaki H; Ludeke BI; Herrmann HD; Kleihues P; Westphal M
Int J Cancer; 1993 Dec; 55(6):982-7. PubMed ID: 8253536
[TBL] [Abstract][Full Text] [Related]
13. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma.
Peller S; Halperin R; Schneider D; Kopilova Y; Rotter V
Oncol Rep; 1999; 6(1):193-7. PubMed ID: 9864427
[TBL] [Abstract][Full Text] [Related]
15. p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas.
Nakamura T; Yana I; Kobayashi T; Shin E; Karakawa K; Fujita S; Miya A; Mori T; Nishisho I; Takai S
Jpn J Cancer Res; 1992 Dec; 83(12):1293-8. PubMed ID: 1483945
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
Yin CM; Yao YF; Yan ZL; Yang HY
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
[No Abstract] [Full Text] [Related]
17. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
18. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
Inoue M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
[TBL] [Abstract][Full Text] [Related]
19. Missense mutations and a deletion of the p53 gene in human gastric cancer.
Matozaki T; Sakamoto C; Matsuda K; Suzuki T; Konda Y; Nakano O; Wada K; Uchida T; Nishisaki H; Nagao M
Biochem Biophys Res Commun; 1992 Jan; 182(1):215-23. PubMed ID: 1370612
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.
Challen C; Lunec J; Warren W; Collier J; Bassendine MF
Hepatology; 1992 Dec; 16(6):1362-6. PubMed ID: 1332921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]